Actively Recruiting
Cardiovascular Risk Assessment in a Cohort of Italian Patients With Type 1 Diabetes Mellitus (CARDT1)
Led by Centro Cardiologico Monzino · Updated on 2024-03-04
200
Participants Needed
2
Research Sites
239 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a multicenter prospective collection of data with diagnostic procedures different from standard clinical care in a specific cohort of patients, aimed to evaluate cardiovascular risk stratification with the European Society of Cardiology (ESC)/European Association for the Study of Diabetes (EASD) guidelines and "The Steno Type 1 Risk Engine" algorithm. The correlation between CVD risk, atherosclerosis, and microvascular complications of diabetes (retinopathy, nephropathy, and neuropathy) will then be evaluated, and the impact of glycemic variability and other glucose metrics on vascular damage will be characterized. The investigators plan to enroll at least 200 consecutive type 1 diabetes mellitus (T1DM) patients who meet all the inclusion criteria and none of exclusion criteria.
CONDITIONS
Official Title
Cardiovascular Risk Assessment in a Cohort of Italian Patients With Type 1 Diabetes Mellitus (CARDT1)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of type 1 diabetes mellitus.
- Age 24 18 years.
- Signed Informed consent
You will not qualify if you...
- Age < 18 years.
- Pregnancy in progress.
- Type 2 diabetes mellitus.
- Secondary diabetes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
IRCCS Centro Cardiologico Monzino
Milan, Italy, 20138
Actively Recruiting
2
Policlinico di Monza
Monza, Italy, 20900
Not Yet Recruiting
Research Team
S
Stefano Genovese, MD
CONTACT
M
Maurizio Rondinelli, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here